These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3199842)

  • 21. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets.
    Stockert JC; Blázquez-Castro A; Cañete M; Horobin RW; Villanueva A
    Acta Histochem; 2012 Dec; 114(8):785-96. PubMed ID: 22341561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
    Vistica DT; Skehan P; Scudiero D; Monks A; Pittman A; Boyd MR
    Cancer Res; 1991 May; 51(10):2515-20. PubMed ID: 2021931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
    Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.
    Buttke TM; McCubrey JA; Owen TC
    J Immunol Methods; 1993 Jan; 157(1-2):233-40. PubMed ID: 8423368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal conditions of chemotherapeutic sensitivity in K562 cell line using tetrazolium dye assay.
    Yu D; Yu LL
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):137-40. PubMed ID: 8352006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Backscattered light confocal imaging of intracellular MTT-formazan crystals.
    Bernas T; Dobrucki JW
    Microsc Res Tech; 2004 Jun; 64(2):126-34. PubMed ID: 15352083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay].
    Kase S; Kubota T; Furukawa T; Yamaguchi H; Takeuchi T; Takahara T; Suto A; Kodaira S; Ishibiki K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2247-53. PubMed ID: 1929445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorimetric assay for cellular activity in microcapsules.
    Uludag H; Sefton MV
    Biomaterials; 1990 Nov; 11(9):708-12. PubMed ID: 2090308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
    Sargent JM; Taylor CG
    Br J Cancer; 1989 Aug; 60(2):206-10. PubMed ID: 2765367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival.
    Sieuwerts AM; Klijn JG; Peters HA; Foekens JA
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):813-23. PubMed ID: 8620058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
    Wilson JK; Sargent JM; Elgie AW; Hill JG; Taylor CG
    Br J Cancer; 1990 Aug; 62(2):189-94. PubMed ID: 2386733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay.
    Yamaue H; Tanimura H; Tsunoda T; Tani M; Iwahashi M; Noguchi K; Tamai M; Hotta T; Arii K
    Eur J Cancer; 1991; 27(10):1258-63. PubMed ID: 1835595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quantification of formazans in tissue sections by microdensitometry. II. The use of BPST, a new tetrazolium salt.
    Altman FP
    Histochem J; 1976 Sep; 8(5):501-6. PubMed ID: 972071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    J Immunol Methods; 1994 Sep; 174(1-2):311-20. PubMed ID: 8083535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
    Cory AH; Owen TC; Barltrop JA; Cory JG
    Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
    Wang H; Wang F; Tao X; Cheng H
    Anal Biochem; 2012 Feb; 421(1):324-6. PubMed ID: 22100715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative study of chemosensitivity tests in vitro for AUC-dependent drugs focusing on the usefulness of MTT assay with drug washout and additional incubation (M-MTT)].
    Takemoto T
    Nihon Ika Daigaku Zasshi; 1993 Jun; 60(3):156-64. PubMed ID: 8331150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer.
    Xu JM; Song ST; Tang ZM; Liu XQ; Jiang ZF; Zhou L; Li YB; Huang Y
    Breast Cancer Res Treat; 1998 Jun; 49(3):251-9. PubMed ID: 9776509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.